GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Rating:
Buy REGN
up 956.14 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Buy with price target $60 by Needham

Posted on: Monday,  May 9, 2011  8:25 AM ET by Needham

Needham rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 05/09/2011, when the stock price was $50.94. Since
then, Regeneron Pharmaceuticals, Inc. has gained 956.14% as of 01/27/2016's recent price of $538.00.
If you would have followed this Needham's recommendation on REGN, you would have gained 956.14% of your investment in 1724 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/9/2011 8:25 AM Buy
None
50.94 60.00
as of 12/30/2011
1 Week down  -0.25 %
1 Month down  -6.71 %
3 Months down  -4.75 %
1 YTD up  8.81 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy